Seal BS - Search Results

1

Clinical and demographic characteristics associated with the receipt of chemotherapy treatment among 7951 elderly metastatic colon cancer patients.

Reese ES, Onukwugha E, Hanna N, Seal BS, Mullins CD. Reese ES, et al. Among authors: seal bs. Cancer Med. 2013 Dec;2(6):907-15. doi: 10.1002/cam4.143. Epub 2013 Oct 10. Cancer Med. 2013. PMID: 24403264 Free PMC article.

2

The economic burden of skeletal-related events among elderly men with metastatic prostate cancer.

Jayasekera J, Onukwugha E, Bikov K, Mullins CD, Seal B, Hussain A. Jayasekera J, et al. Pharmacoeconomics. 2014 Feb;32(2):173-91. doi: 10.1007/s40273-013-0121-y. Pharmacoeconomics. 2014. PMID: 24435407

3

Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.

Zuckerman IH, Rapp T, Onukwugha E, Davidoff A, Choti MA, Gardner J, Seal B, Mullins CD. Zuckerman IH, et al. J Am Geriatr Soc. 2009 Aug;57(8):1403-10. doi: 10.1111/j.1532-5415.2009.02355.x. Epub 2009 Jun 25. J Am Geriatr Soc. 2009. PMID: 19563521

4

Health disparities in staging of SEER-medicare prostate cancer patients in the United States.

Mullins CD, Onukwugha E, Bikov K, Seal B, Hussain A. Mullins CD, et al. Urology. 2010 Sep;76(3):566-72. doi: 10.1016/j.urology.2009.10.061. Epub 2010 Feb 16. Urology. 2010. PMID: 20163844 Free PMC article.

5

Effect of urologists and medical oncologists on treatment of elderly men with Stage IV prostate cancer.

Onukwugha E, Mullins CD, Hsu VD, Seal B, Hussain A. Onukwugha E, et al. Urology. 2011 May;77(5):1088-95. doi: 10.1016/j.urology.2010.11.059. Epub 2011 Mar 25. Urology. 2011. PMID: 21439617

6

Chemotherapy treatment and survival in older women with estrogen receptor-negative metastatic breast cancer: a population-based analysis.

Schneider M, Zuckerman IH, Onukwugha E, Pandya N, Seal B, Gardner J, Mullins CD. Schneider M, et al. J Am Geriatr Soc. 2011 Apr;59(4):637-46. doi: 10.1111/j.1532-5415.2011.03351.x. Epub 2011 Mar 31. J Am Geriatr Soc. 2011. PMID: 21453377

7

Algorithm for identifying chemotherapy/biological regimens for metastatic colon cancer in SEER-Medicare.

Bikov KA, Mullins CD, Seal B, Onukwugha E, Hanna N. Bikov KA, et al. Med Care. 2015 Aug;53(8):e58-64. doi: 10.1097/MLR.0b013e31828fad9f. Med Care. 2015. PMID: 23552436

8

Multispecialist Care and Mortality in Hepatocellular Carcinoma.

Chirikov VV, Mullins CD, Hanna N, Breunig IM, Seal B, Shaya FT. Chirikov VV, et al. Am J Clin Oncol. 2015 Dec;38(6):557-63. doi: 10.1097/COC.0000000000000000. Am J Clin Oncol. 2015. PMID: 24064759

9

Comparative and cost effectiveness of treatment modalities for hepatocellular carcinoma in SEER-Medicare.

Shaya FT, Breunig IM, Seal B, Mullins CD, Chirikov VV, Hanna N. Shaya FT, et al. Pharmacoeconomics. 2014 Jan;32(1):63-74. doi: 10.1007/s40273-013-0109-7. Pharmacoeconomics. 2014. PMID: 24293197

10

Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer.

Onukwugha E, Yong C, Hussain A, Seal B, Mullins CD. Onukwugha E, et al. BMC Med Res Methodol. 2014 Jan 2;14:1. doi: 10.1186/1471-2288-14-1. BMC Med Res Methodol. 2014. PMID: 24383436 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters